Analysis of the application of laboratory tests in the diagnosis of diseases of connective tissue
DOI:
https://doi.org/10.21638/spbu11.2019.426Аннотация
The determination of antinuclear antibodies is included in the criteria for the diagnosis of connective tissue diseases, differential diagnosis and determines the prognosis and treatment tactics of the patient. The existing strategy for laboratory diagnosis of connective tissue diseases involves screening (ANA Hep-2 cell + ENA / ELISA), followed by the selection of refinement tests (ELISA, immunoblot). The assessment of the actually used algorithms, however, revealed that every third patient was assigned almost all available tests simultaneously to confirm a connective tissue disease. Rational screening was performed in 1/3 of the cases. Low frequency of application of ANA immunoblots significantly reduced the effectiveness of diagnosis. It is advisable to provide more information about the primary screening methods for connective tissue diseases of practicing doctors, namely therapists and general practitioners, who act as the primary diagnostic link for this category of patients.
Ключевые слова:
diffuse connective tissue diseases, screening, antinuclear antibodies
Скачивания
Библиографические ссылки
References
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Статьи журнала «Вестник Санкт-Петербургского университета. Медицина» находятся в открытом доступе и распространяются в соответствии с условиями Лицензионного Договора с Санкт-Петербургским государственным университетом, который бесплатно предоставляет авторам неограниченное распространение и самостоятельное архивирование.